ArticleGut and liver2026

High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.

Yeonhong Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.